These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 25294113

  • 21. Atypical Hemolytic Uremic Syndrome in a Pregnant Patient with a Thrombomodulin Gene Variant Treated with Plasma Exchange and Eculizumab.
    Kannan L.
    Am J Case Rep; 2023 Apr 30; 24():e938896. PubMed ID: 37120715
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A.
    Transfus Apher Sci; 2016 Dec 30; 55(3):357-362. PubMed ID: 27742267
    [Abstract] [Full Text] [Related]

  • 23. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
    Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A.
    Ther Apher Dial; 2019 Feb 30; 23(1):4-21. PubMed ID: 30294946
    [Abstract] [Full Text] [Related]

  • 24. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury.
    Cao M, Leite BN, Ferreiro T, Calvo M, Fernández C, Alonso Á, Rodriguez A, Salvador P, Seijo R, Pita S, Arjona E, Rodríguez de Córdoba S, Valdés Cañedo F.
    Am J Nephrol; 2018 Feb 30; 48(3):225-233. PubMed ID: 30205388
    [Abstract] [Full Text] [Related]

  • 25. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A.
    Semin Thromb Hemost; 2014 Jun 30; 40(4):422-30. PubMed ID: 24799305
    [Abstract] [Full Text] [Related]

  • 26. An extremely rare splice site mutation in the gene encoding complement factor I in a patient with atypical hemolytic uremic syndrome.
    Ipe TS, Lim J, Reyes MA, Ero M, Leveque C, Lewis B, Kain J.
    J Clin Apher; 2017 Dec 30; 32(6):584-588. PubMed ID: 28455885
    [Abstract] [Full Text] [Related]

  • 27. Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.
    Fakhouri F, Fila M, Provôt F, Delmas Y, Barbet C, Châtelet V, Rafat C, Cailliez M, Hogan J, Servais A, Karras A, Makdassi R, Louillet F, Coindre JP, Rondeau E, Loirat C, Frémeaux-Bacchi V.
    Clin J Am Soc Nephrol; 2017 Jan 06; 12(1):50-59. PubMed ID: 27799617
    [Abstract] [Full Text] [Related]

  • 28. Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome Due to a Mutation in CFH.
    Habbig S, Bergmann C, Weber LT.
    Am J Kidney Dis; 2016 Mar 06; 67(3):532-3. PubMed ID: 26724167
    [No Abstract] [Full Text] [Related]

  • 29. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2015 Mar 06; 35(5):421-47. PubMed ID: 26456110
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome.
    Lapeyraque AL, Frémeaux-Bacchi V, Robitaille P.
    Pediatr Nephrol; 2011 Apr 06; 26(4):621-4. PubMed ID: 21161283
    [Abstract] [Full Text] [Related]

  • 31. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.
    Am J Kidney Dis; 2014 Jan 06; 63(1):40-8. PubMed ID: 24021908
    [Abstract] [Full Text] [Related]

  • 32. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.
    Pediatr Nephrol; 2016 May 06; 31(5):759-68. PubMed ID: 26604087
    [Abstract] [Full Text] [Related]

  • 33. Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab.
    Yasuda S, Yamamoto M, Fukuda T, Ohtsuka Y, Miura O.
    Intern Med; 2016 May 06; 55(9):1171-5. PubMed ID: 27150874
    [Abstract] [Full Text] [Related]

  • 34. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E, Alberti M, Noris M.
    J Nephrol; 2012 May 06; 25(6):911-7. PubMed ID: 22760880
    [Abstract] [Full Text] [Related]

  • 35. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y, Matsumoto M.
    Rinsho Ketsueki; 2015 Feb 06; 56(2):185-93. PubMed ID: 25765799
    [Abstract] [Full Text] [Related]

  • 36. [Atypical hemolytic uremic syndrome].
    Sepúlveda RA, Tagle R, Jara A.
    Rev Med Chil; 2018 Jun 06; 146(6):770-779. PubMed ID: 30148909
    [Abstract] [Full Text] [Related]

  • 37. Steroid Responsive Atypical Hemolytic Uremic Syndrome Triggered by Influenza B Infection.
    Mittal N, Hartemayer R, Jandeska S, Giordano L.
    J Pediatr Hematol Oncol; 2019 Jan 06; 41(1):e63-e67. PubMed ID: 29702545
    [Abstract] [Full Text] [Related]

  • 38. Three months interval therapy of Eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1/CFH gene.
    Alobaidi S, AlDabbagh A, Alamoudi A, Almowarey M, Akl A.
    CEN Case Rep; 2019 May 06; 8(2):139-143. PubMed ID: 30715674
    [Abstract] [Full Text] [Related]

  • 39. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Brocklebank V, Johnson S, Sheerin TP, Marks SD, Gilbert RD, Tyerman K, Kinoshita M, Awan A, Kaur A, Webb N, Hegde S, Finlay E, Fitzpatrick M, Walsh PR, Wong EKS, Booth C, Kerecuk L, Salama AD, Almond M, Inward C, Goodship TH, Sheerin NS, Marchbank KJ, Kavanagh D.
    Kidney Int; 2017 Nov 06; 92(5):1261-1271. PubMed ID: 28750931
    [Abstract] [Full Text] [Related]

  • 40. Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.
    Povey H, Vundru R, Junglee N, Jibani M.
    Clin Nephrol; 2014 Nov 06; 82(5):326-31. PubMed ID: 23557793
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.